Frost & Sullivan: Molecular Diagnostics & Companion Diagnostics

High convergence of molecular diagnostics and big data analytics will enable predictive analytical capabilities for diagnostic platforms. Several in vitro diagnostic (IVD) companies are expanding their product portfolios to include liquid biopsy and companion diagnostics (CDx) in their long-term strategies. Our research coverage includes tissue diagnostics, liquid biopsy, digital pathology and pre-natal diagnostics and biomarkers for combination therapies.